MedPath

Effect of Two Doses of Coenzyme Q10 on Seminal Fluid and Semen Antioxidant Status

Not Applicable
Completed
Conditions
Male Infertility
Registration Number
NCT03850561
Lead Sponsor
University of Sumer
Brief Summary

The study was conducted to assess the impact of two doses of coenzyme Q10 on seminal fluid parameters and antioxidant status in infertile men.

Detailed Description

The aim of this study was to assess the impact of two doses of coenzyme Q10 on seminal fluid parameters and antioxidant status in infertile men with idiopathic oligoasthenoteratospermia.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
65
Inclusion Criteria
  • History of infertility of at least 12 months despite regular unprotected intercourse.

Oligoasthenoteratospermia was diagnosed by semen analysis showing abnormal sperm concentration (<15 million/ml), progressive motility (<32%), total motility (<40%) and morphology (<30% WHO criteria) as defined by WHO manual for semen analysis 2010

Exclusion Criteria
  • Azoospermia,
  • Varicocele,
  • Genital tract infection,
  • Cryptorchidism,
  • Testicular trauma or scrotal surgery,
  • Endocrine disorder,
  • Systemic illness,
  • Smoking
  • The presence of female factor

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Sperm motility in semen (WHO 2010 guidelines)3 months

Sperm motility (%)

Sperm morphology in semen (WHO 2010 guidelines)3 months

Normal sperm morphology (%)

Semen volume (WHO 2010 guidelines)3 months

Semen volume in ml

Sperm concentration in semen (WHO 2010 guidelines)3 months

Sperm concentration in million/ml

Seminal plasma TAC3 months

Seminal plasma total antioxidant capacity in mmol/ml

Seminal plasma SOD3 months

Superoxide dismutase in U/ml

Seminal plasma CAT3 months

Seminal plasma catalase in U/ml

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fertility Unit, Babyl

🇮🇶

Hilla, Iraq

Fertility Unit, Babyl
🇮🇶Hilla, Iraq

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.